9 results
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
and the recruitment of immune cells, down-regulating it with a biologic can lead to broad anti-inflammatory activity. Within the IL-17 family, IL-17A … in which we may become involved;
recruitment and departures of key personnel;
if any of our product candidates receives regulatory approval
10-Q
2023 Q1
SLRN
Acelyrin Inc
15 Jun 23
Quarterly report
4:19pm
or opposition, interference or cancellation proceeding in which we may become involved;
recruitment and departures of key personnel;
if any of our product
424B4
5ter8e2vw
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
djnvi1ddg2
1 May 23
IPO registration (amended)
6:10am
S-1
ad6a9 gyqbt3cilf
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next